![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
47
PharmaCompass offers a list of Pyridoxal Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyridoxal Phosphate manufacturer or Pyridoxal Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyridoxal Phosphate manufacturer or Pyridoxal Phosphate supplier.
PharmaCompass also assists you with knowing the Pyridoxal Phosphate API Price utilized in the formulation of products. Pyridoxal Phosphate API Price is not always fixed or binding as the Pyridoxal Phosphate Price is obtained through a variety of data sources. The Pyridoxal Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pyridoxal phosphate anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyridoxal phosphate anhydrous, including repackagers and relabelers. The FDA regulates Pyridoxal phosphate anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyridoxal phosphate anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyridoxal phosphate anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyridoxal phosphate anhydrous supplier is an individual or a company that provides Pyridoxal phosphate anhydrous active pharmaceutical ingredient (API) or Pyridoxal phosphate anhydrous finished formulations upon request. The Pyridoxal phosphate anhydrous suppliers may include Pyridoxal phosphate anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Pyridoxal phosphate anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pyridoxal phosphate anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Pyridoxal phosphate anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Pyridoxal phosphate anhydrous DMFs exist exist since differing nations have different regulations, such as Pyridoxal phosphate anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pyridoxal phosphate anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Pyridoxal phosphate anhydrous USDMF includes data on Pyridoxal phosphate anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pyridoxal phosphate anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pyridoxal phosphate anhydrous suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pyridoxal phosphate anhydrous Drug Master File in Japan (Pyridoxal phosphate anhydrous JDMF) empowers Pyridoxal phosphate anhydrous API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pyridoxal phosphate anhydrous JDMF during the approval evaluation for pharmaceutical products. At the time of Pyridoxal phosphate anhydrous JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pyridoxal phosphate anhydrous suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pyridoxal phosphate anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pyridoxal phosphate anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pyridoxal phosphate anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pyridoxal phosphate anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pyridoxal phosphate anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pyridoxal phosphate anhydrous suppliers with NDC on PharmaCompass.
Pyridoxal phosphate anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pyridoxal phosphate anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pyridoxal phosphate anhydrous GMP manufacturer or Pyridoxal phosphate anhydrous GMP API supplier for your needs.
A Pyridoxal phosphate anhydrous CoA (Certificate of Analysis) is a formal document that attests to Pyridoxal phosphate anhydrous's compliance with Pyridoxal phosphate anhydrous specifications and serves as a tool for batch-level quality control.
Pyridoxal phosphate anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Pyridoxal phosphate anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pyridoxal phosphate anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Pyridoxal phosphate anhydrous EP), Pyridoxal phosphate anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pyridoxal phosphate anhydrous USP).